Tweet

@threadreaderapp

This Thread may be Removed Anytime!

Twitter may remove this content at anytime! Save it as PDF for later use!

More from @HanCardiomd

Henry Han, MBBS, MD

@HanCardiomd

13 Dec

@JACCJournals

Evaluation and Management of Patients With Stable Angina: Beyond the Ischemia Paradigm
@JACCJournals @ACCinTouch @DLBHATTMD @ESC_Journals @mmamas1973 @ErinMichos @mirvatalasnag @aayshacader @iamritu @AntoniousAttall @Cosyns @ThorEdvardsen @DavidLBrownMD @venkmurthy
#YesCCT

https://twitter.com/accintouch/status/1337827295067844609

@mmamas1973

📝 Major Clinical Trials for the Management of Stable CHD in the Past 2 Decades

📌COURAGE (2007)
📌BARI-2D ( 2009)
📌STICH (2011)
📌FAME-2 (2012)
📌FREEDOM (2012)
📌ORBITA (2018)
📌ISCHEMIA (2020)
@mmamas1973 @mirvatalasnag @ErinMichos @DavidLBrownMD @DLBHATTMD @iamritu

*COURAGE* (n = 2,287)
PCI + OMT vs. OMT in stable CHD
• All had evidence of ischemia
• 31% triple-vessel CHD
• 4.6 years median follow-up
• HR death/MI 1.05 (95% CI: 0.87 to 1.27

Read 10 tweets

Henry Han, MBBS, MD

@HanCardiomd

12 Dec

@FH_Verbrugge

How can we look for tricky heterogeneity of HFpEF by MMI
Role of MMI in HFpEF . Very nice overview presentation by @FH_Verbrugge #EACVIBestof2020 #EACVIMMI #echofirst @chiarabd @Cosyns @vass_vassiliou @ShelleyZieroth @DrRyanPDaly @rafavidalperez @JGrapsa #whyCMR @iamritu

@chiarabd

Differential Dx on infiltrative CMP and use of echo in HFpEF
#EACVIBestof2020 #EACVIMMI #echofirst @chiarabd @Cosyns @vass_vassiliou @ShelleyZieroth @FH_Verbrugge @DrRyanPDaly @rafavidalperez @JGrapsa #whyCMR @iamritu @mirvatalasnag @MihaiTrofenciuc

@chiarabd

Constriction and Restrictions in HFpEF

#EACVIBestof2020 #EACVIMMI #echofirst @chiarabd @Cosyns @vass_vassiliou @ShelleyZieroth @FH_Verbrugge @DrRyanPDaly @rafavidalperez #whyCMR @iamritu @noshreza @MihaiTrofenciuc

Read 5 tweets

Henry Han, MBBS, MD

@HanCardiomd

12 Dec

@chiarabd

MMI - Multi Modality Imaging in Heart failure and cardiomyopathies
#EACVIBestof2020 #EACVIMMI #echofirst @chiarabd @Cosyns @vass_vassiliou @ShelleyZieroth @FH_Verbrugge @DrRyanPDaly @rafavidalperez @JGrapsa #whyCMR @iamritu @mirvatalasnag @MihaiTrofenciuc

@chiarabd

Role of MMI in Amyloidosis

#EACVIBestof2020 #EACVIMMI #echofirst @chiarabd @Cosyns @vass_vassiliou @ShelleyZieroth @FH_Verbrugge @DrRyanPDaly @rafavidalperez @JGrapsa #whyCMR @iamritu @mirvatalasnag @MihaiTrofenciuc

@chiarabd

Nuclear scan imaging in Amyloidosis and Dx of ATTR-CA

#EACVIBestof2020 #EACVIMMI #echofirst @chiarabd @Cosyns @vass_vassiliou @ShelleyZieroth @FH_Verbrugge @rafavidalperez @JGrapsa #whyCMR @iamritu @mirvatalasnag @MihaiTrofenciuc @MyASNC @RBP0612 @NitiCardio @WilliamZoghbi

Read 5 tweets

Henry Han, MBBS, MD

@HanCardiomd

12 Dec

@escardio

MMI - Role of Multi Modality Imaging in the post ISCHEMIA trial: anatomy vs function?
#EACVIBestof2020 #YesCCT #EACVIMMI @escardio @mmamas1973 @iamritu @Steph_Achenbach @alessia_gimelli @Cosyns @Sarah_Moharem @Giulia_Vinco @Heart_SCCT @DrRyanPDaly @venkmurthy @DFCapodanno

@Cosyns

How to consider To RUDUCE invasive procedures.... and costs after ISCHEMIA Trial
#EACVIMMI #EACVIBestof2020 #YesCCT #whyCMR @Cosyns @Sarah_Moharem @alessia_gimelli @ALEX_MISCHIE @Steph_Achenbach @EAPCPresident @DrMarthaGulati @Giulia_Vinco @mirvatalasnag @EkateriniL

Discussion on ISCHEMIA Trial #EACVIBestof2020 #EACVIMMI #YesCCT #whyCMR

Read 5 tweets

Henry Han, MBBS, MD

@HanCardiomd

11 Dec

@escardio

Enhanced Echocardiography During the COVID-19 Pandemic: clinical practice, patient management and technical optimization #EACVIBestof2020 @escardio @EACVIPresident @Ivan_Echocardio @Sarah_Moharem @WilliamZoghbi @DrRyanPDaly @RyanTedfordMD @JGrapsa @Giulia_Vinco @DrMarthaGulati

@escardio

General Concepts Regarding Ultrasound Enhancing Agent in COVID19
#EACVIBestof2020 #EACVI @escardio @Giulia_Vinco @VLSorrellImages @RyanTedfordMD @iamritu @SuzanneJBaron @susannaprice @alessia_gimelli @ALEX_MISCHIE @mmamas1973 @EkateriniL @CoronaryDoc @DBelardoMD @DrRajivsankar

@Giulia_Vinco

Specific comments and safety of UEA Use in COVID19 #EACVIBestof2020 @Giulia_Vinco @VLSorrellImages @EAPCPresident @mmamas1973 @Sarah_Moharem @EkateriniL @CoronaryDoc @escardio @DrRajivsankar @chiarabd

Read 5 tweets

Henry Han, MBBS, MD

@HanCardiomd

9 Dec

@ShelleyZieroth

This fantastic review on SGLT2-inhibitors; discusses some of the cutting-edge hypotheses & concepts currently being explored around this drug class in an attempt better understand the molecular mechanics of this novel agent link.springer.com/article/10.100… @ShelleyZieroth @AndrewJSauer

@mvaduganathan

SGLT2-inhibitors; more than just glycosuria and diuresis

Early mechanistic work around conventional Tx targets seem to be inconclusive. There are some emerging theories around its effect on myocardial energetics and calcium balance as well as on renal physiology @mvaduganathan

@noshreza

Unlike conventional sodium-driven diuretics, SGLT2i-mediated free water excretion is expected to be more efficient in relieving signs & symptoms of interstitial congestion without adversely compromising intravascular fluid status or causing reflex sympathetic activation @noshreza

Read 9 tweets

Share this page!

Henry Han, MBBS, MD

Try unrolling a thread yourself!

More from @HanCardiomd

Henry Han, MBBS, MD

Henry Han, MBBS, MD

Henry Han, MBBS, MD

Henry Han, MBBS, MD

Henry Han, MBBS, MD

Henry Han, MBBS, MD

Did Thread Reader help you today?

Like this author's thread?